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Introduction. Diabetic retinopathy (DR) is a sight-threatening complication of diabetes. Telemedicine tools can prevent blindness.
We aimed to investigate the patients’ satisfactionwhen using such tools (fundus camera examination) and the effect of demographic
and socioeconomic factors on participation in screening. Methods. Pilot study involving fundus camera screening and self-
administered questionnaire on participants’ experience during fundus examination (comfort, reliability, and future interest in
participation), as well as demographic and socioeconomic factors was performed on 89 patients with known diabetes in Csongra´d
County, a southeastern region of Hungary. Results.Thirty percent of the patients had never participated in any ophthalmological
screening, while 25.7% had DR of some grade based upon a standard fundus camera examination and UK-based DR grading
protocol (Spectra software). Large majority of the patients were satisfied with the screening and found it reliable and acceptable
to undertake examination under pupil dilation; 67.3% were willing to undergo nonmydriatic fundus camera examination again.
There was a statistically significant relationship between economic activity, education and marital status, and future interest in
participation. Discussion. Participants found digital retinal screening to be reliable and satisfactory. Telemedicine can be a strong
tool, supporting eye care professionals and allowing for faster and more comfortable DR screening.
1. Introduction
The global incidence of diabetes mellitus (DM) among adults
(age 18 years and older) was 9% worldwide in 2014 [1],
while its prevalence still shows an increasing tendency due
to obvious obesity epidemic and aging of the population
[2–4]. In Hungary, a total of 865 069 patients (9.5% of the
population) suffered from DM in the same age group in 2011
[5], and some degree of diabetic retinopathy (DR) could be
observed among 19% of the patients with type 1 DM (T1DM)
and 24% in those suffering from type 2 DM (T2DM) for 3 or
4 years [6]. DR is the fourthmost common cause of blindness
in the overall population, but it is in second place among
active adults in industrialized countries [7], accounting for
a significant drop in quality of life (QoF) and working ability
of the patients [8, 9]. In a study comparing data from 35 popu-
lations, the global prevalence of sight-threatening retinopathy
(STR) was estimated at 10.2% for all DMpatients [10]. Known
risk factors for developing DR are age, gender, duration,
and type of DM, elevated HbA
1
c, high blood pressure, and
retinopathy stage, while other correlating risk factors are
being investigated. Unfortunately, 50% of the people with
diabetes are unaware of the characteristics of their disease and
the compliance in attending screening programs is poor. The
disease is determined by the outcome of the complications.
Since high blood sugar and fat destroy the wall of the arteries,
it is not surprising that people with diabetes have 2 to 4
times higher cardiovascular mortality rate and 2 to 4 times
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higher risk of strokes than patients without diabetes. Renal
failure is also a common complication with the estimated
number of 30–40% of the patients with diabetes, while 60–
70% of the patients develop neuropathy. This is not only an
individual problem, but a societal problem as well. According
to a 2009 survey, the average annual health expenditure for
diabetic patients was $1205 per capita and for patients with
complications this number was $2276 per capita. Half of this
cost is made up of drugs, but only a quarter of the cost
spent on drugs is for antidiabetics [11]. Similarly, the treating
expenses doubled in Germany and America, where $174
billion was spent on the treatment of diabetes in 2007 [11].
TheHungarian data cover only the cost of theNationalHealth
Insurance Fund, while there are other economic aspects like
time off fromwork or restricted work due to complications of
the disease. DR is caused by damage to the retinal microvas-
culature. Proper screening for DR is an important milestone
towards achieving early and efficient laser photocoagulation
and/or anti-vascular endothelial growth factor (anti-VEGF)
treatment for preventing visual loss [12]. Depending on
the severity of DR, four stages can be distinguished in
general: preretinopathy (R0), background retinopathy (R1),
preproliferative retinopathy (R2), and active proliferative
retinopathy (R3A) [13]. A further subclassification exists for
stable proliferative retinopathy (R3S) in patients who have
received panretinal laser photocoagulation (PRP) under R3A
and then became “stable”; these cases are considered safe to
keep in a surveillance clinic [14]. Once fundus lesions appear
as a complication of DM, the patient has an apparent DRwith
either low, intermediate, or high risk for developing some
grade of DR.Therefore, the focus should rather be on raising
prevention programs and early detection, as well as successful
treatment of the basic disease.
DR is usually asymptomatic before the appearance of
any vision loss, but it is detectable by retinal imaging
techniques objectively and by accurately taken best corrected
VAmeasurements.Much research around the world has been
focused on the use of telemedicine tools for fundus imaging
and screening, the UK system standing up at the top in terms
of reliability, precision, and standardized input and output.
The results so far have been very promising, with each study
being reported to date pointing out the high sensitivity for
detecting several fundus lesions in the initial stages of DR by
a standard fundus camera and a grading software [15].
The Spectra DR software is designed around the require-
ments of the UK National Health Service (NHS) national
screening program for DR; it is highly complex and requires
a high level of sophistication in the software to meet its
requirements. Spectra DR enables patient appointments to be
created, data entry, image capture, and grading. A generation
of patient results is provided together with a report regarding
the patients’ screening prediction via a “plug-in” algorithm.
With the use of nonmydriatic or investigational hand-held
portable cameras, a quick and simple DR evaluation process
will likely improve the patients’ willingness to participate in
future screening tests.
In 1980, Iceland began regular DR screening for T1DM
patients, which resulted in the reduction of disease-related
blindness from 2.4% to 0.5% [16]. The Icelandic population
being used for the cohort study and development of a
commonly used risk calculator (Risk Medical Solutions,
Iceland) is much more homogenous when it comes to ethnic
and socioeconomic differences compared to the population
in Hungary. Nevertheless, with these new screening and
telemedicine tools, it is realistic to expect similar results to
be achieved in other European countries, including Hungary,
within 5 to 10 years time [17].
The present research explores how DM patients subjec-
tively experience the telemedicine tools and examination
through participation in a free fundus camera screening
program conducted in a southeastern county (Csongra´d)
in Hungary and obtains feedback on whether they would
participate in such an examination in the future. Further-
more, demographic factors such as age, gender, economic
activity, and socioeconomic status (SES) (level of education,
support from family, and subjectively perceived financial
status) are examined for their effect upon participation in
future screening programs.
2. Methods
A free screening test was performed on a random population
including 178 eyes from 89 patients with confirmed DM
diagnosis. Handling of the fundus camera and the image
acquisitions were performed by a qualified professional in a
darkened room, which were then forwarded through a secure
internet connection to a specialist doctor/ophthalmologist
(A. F./M. C. M.) or ROG (G. R./P. K.) for evaluation. In
case of constricted pupil, another image was taken after
ensuring normal intraocular pressure level and applying
cyclopentolate (5mg/mL) eye drops to achievemydriasis.The
assessment of the fundus images was performed within 10
working days using SpectraDR software.The recordings were
safely deposited and kept inaccessible to third parties for 10
years at a central server, so that later they can be used in
further comparative studies on DR.
The images were acquired by an 18-megapixel Canon EOS
digital camera which was connected to a Canon CR2 color,
nonmydriatic, 45∘ retinal camera. Two pictures were taken of
the participants’ each eye: one with the macula and another
with the optic nerve in the center—this is in line with the UK
screening requirements [18]. In case of presence of amblyopia
or nontransparent media (e.g. cataract and corneal or visual
axis obstructing conditions), the patients were excluded from
the study. During image evaluation, the graders (A. F./M.
C. M./G. R./P. K.) classified the signs and the stages of DR
and maculopathy in the standardized UK-based software
Spectra DR and graded the images in alignment with the UK
standard grading protocols [19]. Each image was evaluated
in two stages: first, the ROG (G. R./P. R.) evaluated them,
and then a supervisor/ophthalmic consultant confirmed the
diagnosis (A. F./M. C. M.). At the end, an expert opinion
regarding the grade of retinopathy was sent back to the
screening site, that is, stage of retinopathy (R0/1/2/3A/S)
and absence or existence of maculopathy (M0/1). Other
discovered abnormalities were not diagnosed in this study,
although they were recorded, as they can provide further
information about other symptomswhichmay have occurred
Journal of Diabetes Research 3
in the past, and therefore may require medical attention over
a specified period of time.
The classification of the DR was as follows:
M0: no maculopathy was detected; repeated screen-
ing was recommended one year later.
M1: there was a sight-threatening maculopathy; with-
in one month a medical examination is required.
R0: there was no clinical anomaly; repeated screening
was recommended one year later.
R1: mild nonproliferative phase, microaneurisms,
dot- or blot-like hemorrhages, or exudates could be
seen; control examination was recommended one
year later.
R2: moderate or severe nonproliferative phase, major
bleeding(s), cotton-wool spots, venous looping, and
intraretinal microvascular abnormalities (IRMAs)
were visible; control examination was required within
one month.
R3A: active proliferative phase, neovascularization of
the optic disc (NVD) or elsewhere (NVE) or prereti-
nal bleeding(s), vitreous bleeding, preretinal fibrosis,
and tractional retinal detachment could be observed;
immediate medical examination was required within
two weeks.
R3S: stable proliferative retinopathy; a retinal image
showing stable post-PRP laser with no signs or reac-
tivation or active referable retinopathy; only to be
determined in the presence of “benchmark images”
taken at the time of discharge for comparison; screen-
ing intervals may be at the discretion of the trained
ROG.
Other recorded, but not reported, changes/fundus pathology
included age-related macular degeneration (AMD), glau-
coma changes in the optic nerve, and any other signs of eye
disease.
2.1. Self-Completed Questionnaire. The self-completed ques-
tionnaire collected information about the individual’s demo-
graphic status such as age, gender, economic activity (full-
time, part-time, and retired), SES such as education (primary,
secondary, and higher), and marital status (married or lives
with a partner, single, separated or divorced, and widowed).
The general part of the questionnaire was based on the
EuropeanHealth Interview Survey 2009 [20], and it collected
data about DR associated exposure parameters and some
other health connected parameters, type of DM, or presence
of hypertension, as well as the type of eye diseases. Further-
more, data were collected about the frequency of measuring
blood sugar levels and also about participation in screening
programs, which are important for preventing retinopa-
thy, including the frequency of attending Diabetology or
Ophthalmology specialist clinics. Questions regarding the
perceived reliability of results (yes/no/maybe), willingness
to participate again (yes/no/maybe), comfortability (dissat-
isfied/satisfied/acceptable) of the tests performed, and the
overall perception of the screening examinations as well as
whether they would participate in a similar examination next
time were being asked/collected as well. Some categories
underwent merging due to missing data, for example, the
intensity of blood sugar measurement (monthly/less than a
month, weekly/every few days, and daily/more than once a
day). If the participants could not understand or read the
questionnaire for whatever reason, they received professional
help accordingly.
2.2. Statistical Analysis. The analysis of the data was per-
formed by descriptive statistical analysis on𝑁number of par-
ticipants, and percent distribution, median, and interquartile
range (IQR) are being shown.TheChi-square (𝜒2) and Fisher
exact tests were used to test differences of the distributions of
categorical variables. The relationship between two variables
was considered statistically significant when 𝑃 < 0.05.
The graphs were made in GraphPad Prism 5.01 (GraphPad
Software Inc., La Jolla, CA, USA). The statistical analysis of
the data was performed by using Stata (Intercooled Stata
8.0, Stata Corporation, College Station, TX, USA) and Excel
software (Microsoft Corporation, USA).
2.3. Ethical Issues. The Regional and Institutional Human
Medical Biological Research Ethics Committee of the Albert
Szent-Gyo¨rgyi Health Centre, University of Szeged, approved
the study protocol (number 197/2015).The research provided
anonymity to the participants. Before the beginning of a test,
the participants signed a written consent form in which they
agreed to permit the use of data for research purposes.
3. Results
178 eyes of 89 people were examined in the study out of which
30 were men (33.7%) and 59 were women (66.3%). Table 1
shows the demographic characteristics of the patients, the
median age of whom ranged between 56 and 68 years of
age and had median HbA1c of 7.2% (ranging between 6.4
and 7.9%). Table 2 shows the distribution of the types of
DM and the stages of DR in the screened population, based
upon and compared to the UK grading system and software
(Spectra DR). Twenty percent of the participants had T1DM
out of which 70.8% had T1DM diagnosed by a Diabetology
department, the rest being yet undiagnosed or hidden disease
patients. Mild nonproliferative DR (grade R1) was detected
in 23.0% of the participants, while higher (moderate/R2 and
proliferative/R3) grade DR was detected in 1.4% and 1.4%
of the subjects, respectively; maculopathy/M1 was present in
5.4% of the studied group (representative images from these
were captured from each grade and processed in the Spectra
software as shown in Figure 1). Another retinal pathology
was detected in 28.4% of the participants. There was an
overall left-shift in the distribution of earlier stages of DR in
the UK population compared to the one represented by the
Hungarian graded images and based upon the Spectra DR
software, probably due to the existence of a well established
screening system in theUK and early detection of the disease.
According to the self-perceived satisfaction with the
classical pupil dilation versus fundus camera examination,
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Table 1: Patients’ demographics.
Variables Percent (%)
Gender
Male 33.7%
Female 66.3%
Age (median, IQR) 63 (56–68)
HbA1c (median, IQR) 7.2 (6.4–7.9)
Hypertension∗
No 19.1%
Yes 76.4%
Occupation
Full-time 22.2%
Part-time 9.3%
Retired 68.5%
Education∗
Primary 23.6%
Secondary 52.3%
Higher 21.8%
Marital status
Married or lives with a partner 55.6%
Single, separated, or divorced 24.1%
Widowed 20.4%
Attendance of blood sugar screening
Monthly/less than a month 20.8%
Weekly/every few days 39.6%
Daily/more, than once a day 39.6%
IQR: interquartile range.
∗Theremaining percent of participants either were not aware of their disease
(hypertension) or provided no response (education).
20.4% versus 83.6% of the participants expressed satisfaction,
respectively, while 37.0% versus 9.1% were unsatisfied, and
42.6% versus 7.3% could not decide. The classical pupil
dilation versus fundus camera examination was found to be
definitely reliable by 75.5% versus 72.0%, possibly reliable
by 18.4% versus 16.0%, and unreliable by 6.1% versus 12.0%,
respectively. The willingness to participate in a classical pupil
dilation versus fundus camera examination was found to
be positive by 78.2% versus 67.3%, while 9.1% versus 10.9%
responded that they would not participate, and 12.7% versus
21.8% responded as maybe doing it. There was no significant
difference between the satisfaction from the examination
(𝑃 = 0.9) and reliability (𝑃 = 0.3), although the willingness to
participate significantly differed between the classical versus
fundus camera examination (𝑃 = 0.01) (Table 3).
The economic activity significantly affected the participa-
tion in a blood sugar screening (𝑃 = 0.001). Sixty percent of
those employed in a part-time job had attended blood sugar
screening more than once a day or daily, 20% weekly/every
few days or monthly/less than a month. The daily/more
than once a day attendance was 33.3% among retired, while
the weekly/every few days screening was 55.6%, and the
monthly/more than a month was 11.1% in this age/patient
group. Among the full-time workers, the daily/more than
once a day and monthly/less than a month screening was
45.5% versus 54.5% (Figure 2(a)). Similarly, marital sta-
tus (being married or living with a partner) significantly
impacted the likeliness to attend blood sugar screening (𝑃 =
0.04); this population had a higher daily/more than once a
day blood sugar screening attendance, with a frequency of
50% compared to those living alone (single, separated, or
divorced: 30.8%; widowed: 18.2%); the latter two populations
had otherwise the highest weekly/every few days attendance
(single, separated, or divorced: 53.9%; widowed: 72.7%).
The least frequent or monthly/less than a month screening
attendance was the highest among married or living with a
partner population (28.6%), while it was the smallest among
widowed participants (9.1%) (Figure 2(b)).
The willingness to participate in the annual fundus cam-
era screening was the highest among the full-time workers
(91.7%) and the lowest among part-time workers (20.0%)
Those who reportedmaybe versus no attendance were higher
among part-time workers (40.0% versus 40.0%, resp.), while
the willingness to participate differed significantly between
the analyzed economical groups (𝑃 = 0.003) (Figure 3(a)).
The satisfaction with the fundus camera screening also
increased significantly with the level of education (primary
(69.2%) and secondary (82.8%); higher (100%), 𝑃 = 0.003)
(Figure 3(b)).
Among participants with secondary or higher education,
themost common argument used against the classical fundus
exam was “I cannot see clearly after.” The participants with
primary school level education had significantly higher rate
of stating dissatisfaction of the pupil dilation examination.
This reason was not stated among higher educated patients,
although the “I cannot drive after” reason seemed to appear
more often in this group of patients.
4. Discussion
The present study aimed to investigate the patients’ experi-
ence with the use of telemedicinal tools for screening of DR
and the ability to collect the parameters needed to calculate
DR risk (age, gender, type and duration of DM, HbA1c,
hypertension, and fundus image grading) in a southeastern
county (Csongra´d) in Hungary. The justification for using
health care tools aimed at screening DR is high, due to the
great availability of tools for DR prevention and avoidance of
late complications such as STR. The population of Csongra´d
County is very plausible for initiating such a study, since it
has a known higher prevalence of DM compared to other
counties in Hungary [5]. In addition, the study followed
the progressive trend of DM worldwide and examined the
willingness to participate in screening tests, the attitude
towards screening examination, and the influence of demo-
graphics and socioeconomic factors like education, financial,
and marital status. Regarding the risk factors, the SES has
been already shown to have a very significant impact on
the attendance in screening examinations, while occupation
has been related to a greater impact on nonattendance in
screenings [21]. The screening frequency for blood sugar
levels in full-time workers was indeed significantly lower
in our study, but the willingness to participate in fundus
screening examination was higher in that subpopulation.
Journal of Diabetes Research 5
Table 2: Distribution of the DM types and DR grade in the studied population in relation to the UK-based grading system implemented by
the Spectra analysis.
T1DM T2DM R0 R1 R2 R3 M1
Csongra´d County, Hungary 20.2% 79.8% 73.0% 23.0% 1.4% 1.4% 5.4%
East Anglia, UK 15.0% 85.0% 68.7% 27.5% 0.6% 0.3% 3.2%
(a) R0 (b) R1
(c) R2 (d) R3A
(e) M1
Figure 1: Spectra DR based grading of the DR retinopathy. Representative images of the different grading stages are shown in the studied
population.
From the standpoint of DR formation and progression, it
is 76.4% of the patients who had high blood pressure which,
by itself or as a codisease, gives poorer prognosis for the
DM patients due to a predisposition for premature vascular
sclerosis. The occurrence of DR in the studied sample pop-
ulation was 25.5%, which is higher than any previous results
in Hungary [22], although somewhat expected in Csongra´d
County.
Although the Diabetology guidelines recommend blood
glucose levels to be checked several times a day, only a little
over a quarter of the participants performed it accordingly.
Strikingly, 60% of the study participants performed blood
glucose testing every few days, if not more rarely. Upon diag-
nosis with DM, the Diabetologist or the General Practitioner
informed the patient of the possible complications from the
disease and recommended an annual eye screening test. Our
results coincide with the International Diabetes Federation’s
(IDF’s) observation that 50% of the people with DM are not
aware of the characteristics of their disease [23]. In Hungary,
the number of known patients with diabetes makes nearly
10% of the total population. It would take 100 ophthalmol-
ogists (from the total of 968 practicing) working full-time
if they want to carry out only the annual screenings by
using traditional tools on such a sized population. This may
change by using the telemedicine system [17]. Introducing a
new screening program always faces challenges, but previous
studies from other countries show promising results. DR
could be detected at early stages by digital imaging even in
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Table 3: Reliability, satisfaction, and willingness to participate again in a classical or fundus camera examination for DR screening.
Variables
Pupil dilation Fundus camera
𝑃∗𝑁 = 89 𝑁 = 89
(%) (%)
Reliability of the examination
Yes 75.5% 72.0%
0.3No 6.1% 12.0%
Maybe 18.4% 16.0%
Willingness to participate again
Yes 78.2% 67.3%
0.01∗No 9.1% 10.9%
Maybe 12.7% 21.8%
Satisfaction with the comfort of the screening
Dissatisfied 37.0% 9.1%
0.9Satisfied 20.4% 83.6%
Acceptable 42.6% 7.3%
∗
𝑃 < 0.05.
rural areas [24]. Diabetes causing vision loss is successfully
confined in countries like Iceland, where regular screening
was implemented.
In our study, only a third of the participants had not
visited an ophthalmologist, while 12.4% of them have been
diagnosed with DM within a year; only 56.2% of the partic-
ipants complied with the one-year recommendation. In the
UK, patients compliance in attending traditional screening
was 45% and 50% in fundus camera screening in the first year
[25]. After using a mobile fundus camera screening unit to
reach more patients, the compliance elevated to 80% in the
fifth year [26]. Compliance is a highly influential factor of cost
effectiveness because of the fixed costs (digital imaging cam-
era, computer system, etc.) [25]. Patient satisfaction affects
the attendance rate of the screening. The response to the
subjective experiences perceived during fundus examination
did produce satisfactory results: more than three-quarters
of the participants were satisfied with the fundus camera
examination and one out of five with the traditional method.
In both cases, three-quarters of the participants considered
the results of the study to be reliable, a significant difference
being found between the two screening procedures. There
were fewer problems than expected (e.g., subjects being not
able to drive after pupil dilation), but it can be a factor
which is most likely related to older age of the sampled
population. It is interesting to note, however, that during the
procedure of pupil dilation, one quarter of the subjects found
administering eye drops being irritating or uncomfortable, in
particular, those who had lower education.
There is a level of contradiction in the assessment of
reliability and satisfaction in the study, since significantly
more people were willing to participate in the traditional
retinal screening method than in the fundus camera test
(78.2% versus 67.3%). A possible weakness of the study is the
size of the sample. 83.6% of the participants were dissatisfied
with the examination, which raises the suspicion they could
have chosen “Other” for their response to having no other
comments, and this could have been done out of necessity.
Among the inconvenience experienced during the test with
pupil dilation, the “Other” category was chosen by only 4.1%
in which no mention of any reasons for the selection made
was stated whatsoever.
During the analysis, the economic activity and education
appeared to pose an effect on the individual’s willingness to
participate in the screening test. The fundus camera test was
preferred mostly by the full-time employees, with whom it
was presumably important to see well after the test in order
to be able to continue their work during the same day. Based
on the level of education, the few subjects that evaluated the
fundus camera test as satisfactory were those who found eye
drops to be the most uncomfortable in the traditional test.
These data are somewhat contradictory, as mydriatic drops
are always required in traditional testing. People with higher
education found only the driving restriction and the bad sight
after the examination as a negative aspect of the screening; in
this context, they were 100% satisfied with the fundus camera
test.
The telemedicine part of the study also concerns data
safety and patient anonymity preservation which are now
guided by an EU law contained in the Charter of Fundamen-
tal Rights of the European Union, Article 8 (2000/C 364/01)
[27], as well as the need to safely store and make backup files
for high resolution fundus images acquired from the patients
and their retention; these rules were followed in the present
study entirely. The issue of having decentralized and near
the patient DR screening and fundus imaging services and
centralized image reading remains to be evidenced in future
telemedicinal studies for screening DR in Hungary, the UK
grading system being the golden standard for achieving the
task properly.
In conclusion, the analyzed demographic and socioe-
conomic factors showed a significant relationship with the
future participation in the fundus camera screening for DR.
The participants’ age or gender appears not to affect the
experience (satisfaction) of the examination (e.g., fundus
examination under pupil dilation). However, the level of
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Figure 2: Effect of economic activity (a) and marital status (b) upon the blood sugar screening frequency.
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Figure 3: Economic activity in relation to willingness (a) and educational level in relation to satisfaction (b) in participating in fundus
screening examination.
education appears to have an important role: higher educated
patients were more likely to participate in pupil dilation
examination using an ophthalmoscope. This is in contra-
diction to the fact that only slightly more than half of
the participants in this group took part in such screening
examination within a period of one year. It was also not
confirmed that the distribution of DR grades in this study
is similar to the results of previous national studies [17,
22], as Csongra´d County is not a representative population
comparable to other parts ofHungarywhere the prevalence of
DM and DR is lower. Further research is therefore needed on
a larger ormore representative sample fromdifferent counties
in Hungary where the percent of distribution of patients
diagnosed with DM varies.
In general, the treatment of DM patients is an inter-
disciplinary task of primary care physicians, diabetolo-
gists/dietologists, ophthalmologists/optometrists, and public
health specialists. These professionals are responsible for
giving lifestyle advice and for directing patients towards
more appropriate screening tests. Ophthalmic monitoring
is required every year after the diagnosis of diabetes and
every other year for patients with excellent glycemic control
without retinopathy at the previous examination but annually
if there are risk factors [28]. Furthermore, if retinopathy
is manifested to some degree, the screening time should
be reduced to half a year (in the case of nonproliferative
retinopathy) and three months (for preproliferative retinopa-
thy). In case of proliferative retinopathy patients should go
8 Journal of Diabetes Research
immediately to an ophthalmologist, in order to initiate laser
treatment in time and thus save the eye from STR. The
present state, unfortunately, seems to involve lack of realistic
assessment or judgment of the risk from complications
by the patients, and therefore a neglect to participate in
the recommended screening tests. Constant maintenance of
normal blood sugar levels is indispensable. Fast, easy, and
accurate fundus camera examination is an alternative to
the traditional, time-consuming, and “unsatisfactory” fundus
test under pupil dilation.The patients, who tried thismethod,
agreed that this new way is more satisfaction than the one
they got used to, while they appreciated its reliability in the
same way. Indeed, in the UK, due to the systematic screening
implemented, DR is no longer the leading course of blindness
in the working age population [29].
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